Bruno Sangro, Thomas Yau, Anthony B. El‐Khoueiry, Masatoshi Kudo, Yun Shen, Marina Tschaika, . . . Urvi Aras. (2023). Exposure‐response analysis for nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma (CheckMate 040). Wiley.
Chicago Style (17th ed.) CitationBruno Sangro, et al. Exposure‐response Analysis for Nivolumab Plus Ipilimumab Combination Therapy in Patients with Advanced Hepatocellular Carcinoma (CheckMate 040). Wiley, 2023.
MLA (9th ed.) CitationBruno Sangro, et al. Exposure‐response Analysis for Nivolumab Plus Ipilimumab Combination Therapy in Patients with Advanced Hepatocellular Carcinoma (CheckMate 040). Wiley, 2023.
Warning: These citations may not always be 100% accurate.